Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$46.5K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 17,784 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 21,263 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 5,088 | — | — | -100.0% | Open the original filing on SEC.gov |
| Aug 15, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 2,600 | — | — | — | Open the original filing on SEC.gov |
| Aug 15, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 2,600 | $19.62 | $51K | +10.9% | Open the original filing on SEC.gov |
| Jun 30, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 299 | $23.87 | $7.1K | +1.3% | Open the original filing on SEC.gov |
| Jun 18, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 848 | $54.84 | $46.5K | -3.5% | Open the original filing on SEC.gov |